Ceftaroline for complicated skin and skin-structure infections.

scientific article published on May 2010

Ceftaroline for complicated skin and skin-structure infections. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1517/14656561003777026
P698PubMed publication ID20402556

P50authorG Ralph CoreyQ115862748
Martin E StryjewskiQ115862786
Esteban C NanniniQ39392197
P2860cites workIncreased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year periodQ41066970
In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber modelQ42111513
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis modelQ42627381
Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumoniaQ43153489
In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599.Q45004641
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ46826194
Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.Q54120637
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.Q54440265
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.Q55067143
Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentQ55897489
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infectionsQ24672937
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureusQ28362193
Invasive methicillin-resistant Staphylococcus aureus infections in the United StatesQ29616087
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance studyQ29616607
Clinical practice. Infection associated with prosthetic jointsQ33771840
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strainsQ33938055
TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological propertiesQ33965890
Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibioticsQ34012457
Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic targetQ34510488
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistanceQ34547868
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ34783668
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory careQ36023547
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureusQ36482771
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniaeQ37072096
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infectionsQ39744021
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)1197-1206
P577publication date2010-05-01
P1433published inExpert Opinion on PharmacotherapyQ5421212
P1476titleCeftaroline for complicated skin and skin-structure infections
P478volume11

Reverse relations

cites work (P2860)
Q57210839Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus
Q37809059Current medical management of diabetic foot infections
Q37800939Invasive community-associated MRSA infections: epidemiology and antimicrobial management
Q37942654Will new antimicrobials overcome resistance among Gram-negatives?

Search more.